Ishita Drugs Board Meeting on 30 May 2026 to Approve Results

Ishita Drugs & Industries Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider the Directors' Report, Corporate Governance Report, Management Discussion and Analysis Report, and the notice for the 33rd Annual General Meeting. Re-appointment of internal auditors and disclosure of director's interests are also on the agenda. The trading window is closed from April 1, 2026, until 48 hours after the results announcement.